CervoMed Inc.
Last updated September 27, 2026
Organization details
- Legal name
- CervoMed Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- CRVO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001053691
Board of directors
-
Diana M. Lanchoney · DirectorSince 2023
-
Frank Zavrl · DirectorSince 2023
-
Jane H. Hollingsworth · DirectorSince 2023
-
Jeffrey Poulton V · DirectorSince 2023
-
Jill Davidson · DirectorSince 2023
-
John J. Alam · Director · CEO & PresidentSince 2023
-
Joshua S. Boger · DirectorSince 2024
-
Marwan Sabbagh · DirectorSince 2023
-
Robert Joseph Cobuzzi Jr. · Director · President & CEOSince 2023
-
Sylvie Gregoire · DirectorSince 2023
Chief executives
John J. Alam
· CEO & President
Since August 2023
Robert Joseph Cobuzzi Jr.
· President & CEO
Until August 2023
· Former
Board connections
2 of this board's directors also sit on 2 other boards.
- via Jeffrey Poulton V
- via Sylvie Gregoire
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 27, 2024 | ELDER WILLIAM ROBERT Officer (CFO & GC) | Open-market purchase | +1,000 | $18.16 | $18,160 |
| Feb 26, 2024 | Joshua S. Boger Director, 10% owner | In-the-money exercise | +495,995 | — | — |
| Feb 26, 2024 | Joshua S. Boger Director, 10% owner | Open-market sale | −36 | — | — |
| Nov 9, 2023 | Sylvie Gregoire Director, 10% owner | Gift | −10,000 | — | — |
| Nov 9, 2023 | John J. Alam Director, Officer (CEO & President), 10% owner | Gift | −12,500 | — | — |
| Aug 31, 2023 | Jane H. Hollingsworth Director | Option exercise | +122 | — | — |
| Aug 31, 2023 | Jane H. Hollingsworth Director | Sold back to the company | −45 | — | — |
| Jun 30, 2023 | Diana M. Lanchoney Director | Option exercise | +232 | — | — |
| Jun 30, 2023 | Diana M. Lanchoney Director | Sold back to the company | −85 | — | — |
| May 31, 2023 | Jane H. Hollingsworth Director | Option exercise | +183 | — | — |
| May 31, 2023 | Jane H. Hollingsworth Director | Sold back to the company | −68 | — | — |
| Mar 31, 2023 | Diana M. Lanchoney Director | Option exercise | +232 | — | — |
| Mar 31, 2023 | Diana M. Lanchoney Director | Sold back to the company | −85 | — | — |
| Feb 28, 2023 | Jane H. Hollingsworth Director | Option exercise | +183 | — | — |
| Feb 28, 2023 | Jane H. Hollingsworth Director | Sold back to the company | −68 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.